お問い合わせ
All employees or service providers of the British Columbia Ministry of Health and Health Insurance who process or have access to confidential PharmaNet information or documents are subject to confidentiality provisions such as the duration of their employment or contract. Pharmacists, other members of the health care team, managed health systems and pharmacy benefit managers have a legal, social and ethical responsibility to ensure that: The Ministry of Health and Health Insurance`s BC Medical Device Distributor Claims Access confidentiality agreements require compliance with the confidentiality requirements set out in PharmaNet`s policies and procedures (PDF, 3.3 MB), which the completed forms must be retained by the pharmacy for the purposes of the CPBC during the employee`s employment and for at least three years after the end of the employee`s employment. PharmaCare requires that these documents be kept for four years. All PharmaNet users with access to patient information are required to sign confidentiality agreements. No additional confidentiality obligation is required for pharmacists as they have already signed a confidentiality agreement that will be maintained by the College of Pharmacists of British Columbia. It is the responsibility of the pharmacy manager to ensure that everyone understands the forms to be signed and that all employees follow confidentiality procedures. Confidentiality Agreements for Medical Device Distributors Pharmacists and other healthcare professionals who use patient data must ensure that a balance is maintained that ensures patient privacy without restricting access to information that would compromise the provision of high-quality care to individuals and the public good. Healthcare professionals can help maintain this balance through the use of advanced technologies that provide a high level of security for computerized medical and pharmaceutical records and other electronic data systems used to capture PSR. In addition, health care professionals must identify and comply with regulations that describe the disclosure conditions where the patient`s record must be noted when PSRs are disclosed. Designated support persons who work in more than one pharmacy must sign a confidentiality agreement in each pharmacy, even if all pharmacies are part of the same chain.
20. Entire Agreement; Modification. This Agreement constitutes the entire agreement between HHSC and External with respect to the subject matter hereof and supersedes all oral or written agreements, understandings and communications relating to such subject matter between HHSC and Extern prior to the date of this Agreement. This Agreement may only be modified or supplemented by a letter duly authorized and signed by either party to this Agreement. This Agreement may not be modified or modified by oral agreements or agreements between the parties unless it is reduced to writing, duly approved and signed by both parties. Privacy and confidentiality have long been recognized as essential elements of the relationship between patients, pharmacists, physicians and other health professionals. Creating a complete and accurate medical record is essential for optimal patient care. To provide high-quality patient care and assess the health status of enrolled populations, managed healthcare systems must compile, integrate, and provide rapid access to complex patient information from a wide range of providers, provider organizations, data sources, and users. The increasing use of new information technologies offers many opportunities to improve patient care. However, the increased use of these new technologies has also raised concerns about the need to protect patients` right to privacy and to restrict access to protected medical and pharmaceutical information.1 The confidentiality agreement adapted to anyone with access to the pharmacy must be used: Confidentiality agreements of Community health practice The signing of an agreement applies to: for a pharmacist for all stores in which he can work, provided that the company is registered with the university.
Adequate patient care requires access to and review of medical and apothecal information identifiable by the patient to ensure that the patient receives appropriate drug treatment and achieves optimal results from that treatment. Physicians at the managed care pharmacy rely on phi to protect the patient from inappropriate drug uses, such as . B combinations of drugs that can lead to dangerous interactions, drugs to which a patient may be allergic or drugs that may be contraindicated in certain diseases or pregnancy. This review process is not always obvious to the patient.4 Healthcare professionals in managed care pharmacy are uniquely placed for services that manage a patient`s drug treatment, which includes assessing the patient`s medication needs, preventing adverse drug reactions, developing a patient-specific treatment, treatment of chronic diseases and drug treatment, which ensure continuous monitoring, which may include promoting the patient`s responsibility for their own care. and the efficient use of scarce resources in the field of health care. Each pharmacy must have a system in place to ensure that commitments are regularly signed, deposited in the pharmacy and made available to college representatives. EDAP requires compliance with the confidentiality requirements set out in the BC Professional and Software Conformance Standards Volume 3C: Business Rules – PharmaNet (PDF, 947 KB), including a copy to be given to the employee and the original submitted to the pharmacy. Health Promotion and Disease Management: Patient-identifiable pharmaceutical information is currently used for disease management programs to monitor patient adherence and clinical indicators of disease status, determine the need for treatment modification, and inform patients of screening and assessment procedures required for many conditions.
Patient confidentiality refers to maintaining the private nature of health data specific to an individual patient. The following definitions can help to understand this concept: Responsible use of PSR improves the efficiency and quality of health services for patient groups with similar needs. The patient`s right to confidentiality of their identifiable medical information often prevents access to that information for reasons other than those authorized regarding treatment, payment or surgery. In order to maintain patient confidentiality and provide high-quality, cost-effective care to patients with similar treatment needs, managed healthcare systems develop privacy policies and procedures that meet legal requirements and balance the need to ensure an individual patient`s right to privacy with the need for physicians, managed health systems and payers, exchanging information to prove the quality of care provided. Individuals must be assured that those who have access to their confidential medical records will comply with laws and principles of ethical conduct to protect this information from inappropriate disclosure, and that the responsible and prudent use of this information will improve their medical care. Managed health care systems therefore implement programs that ensure these requirements. 1. Confidential Information. It is recognized and agreed that all trade secrets, business plans, marketing plans, know-how, data, contracts, documents, scientific and medical concepts, billing records, personnel records, medical records of any kind and reference resources for existing or future services, products, operations, management, business, pricing, financial situation, evaluations, business plans, objectives, strategies, objectives and agreements of the pharmacy and all their facilities, affiliates or subsidiaries, and all patient information, whether written or oral, are confidential (“Confidential Information”); provided, however, that confidential information, other than patient information, does not include publicly available information. .
